Draft Details

Designation:CSA ISO 5649:26
Source:CSA
Review start date:Oct 14, 2025
Review end date:Dec 13, 2025
Contact email:angelique.coyle(at)csagroup.org
Associated materials (click link to download). You will need to be logged in to download any files:

Adobe Acrobat For PDF files, Adobe Acrobat Reader can be downloaded from the Adobe website.

Draft Scope/Description:

This document establishes requirements for assuring quality, safety, performance and documentation of laboratory-developed tests (LDTs) as per their intended use for the diagnosis, prognosis, monitoring, prevention or treatment of medical conditions.

It outlines the general principles and assessment criteria by which an LDT shall be designed, developed, characterized, manufactured, validated (analytically and clinically) and monitored for internal use by medical laboratories.

The scope includes regulatory authority approved IVD medical devices that are used in a manner differing from approved labelling or instructions for use for that device (e.g. use of a sample type not included in the intended use, use of instruments or reagents not included in the labelling).

While this document follows a current best practice and state-of-the art approach, it does not provide specific details on how to achieve these requirements within specific disciplines of the medical laboratory nor specific technology platforms.

This document does not specify requirements for examination procedures developed by research or academic laboratories developing and using testing systems for non-IVD purposes. However, the concepts presented in this document can also be useful for these laboratories.

This document does not apply to the design, development and industrial production of commercially used IVD medical devices.

You may comment on any section of this document by clicking the “Submit Comment” link at the bottom of the relevant section.